Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Milmoe William H.10% Owner | Other acquisition or disposition | J | $4.65M 120.0K sh | Jan 21, 2026 |
| 21 | Landman YoavDirector, CHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $1.21M 21.1K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 21 | Stephens JimPresident, CRM & Neuro | Option exercise | M | — 758 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | Open-market sale · 10b5-1 plan | SELL | $7,677 28 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | Open-market sale · 10b5-1 plan | SELL | $17K 60 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 20 | Ugwumba Chidozie10% Owner | Open-market sale | SELL | $41K 7,923 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 20 | Salisbury Robert WebbExecutive VP and CFO | Tax withholding | F | $99K 3,210 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | Open-market sale · 10b5-1 plan | SELL | $12K 44 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 20 | Jenkins Robert MExecutive VP and COO | Tax withholding | F | $155K 5,152 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | Open-market sale · 10b5-1 plan | SELL | $49K 174 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | Open-market sale · 10b5-1 plan | SELL | $18K 64 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | Open-market sale · 10b5-1 plan | SELL | $33K 118 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | Open-market sale · 10b5-1 plan | SELL | $18K 64 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | Open-market sale · 10b5-1 plan | SELL | $36K 129 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 19 | Goldstein Robert L.Chief Operating Officer | Grant or award | A | — 4,348 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Trahan JeremyGeneral Counsel | Tax withholding | F | $12K 1,595 sh | Jan 21, 2026 traded Jan 17, 2026 |
| 19 | Hazelbaker JillSee Remarks | Option exercise | M | — 2,546 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Sicinski Matthew B.Senior VP and CAO | Option exercise | M | — 3,593 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Deneke J HeathChairman, President and CEO | Option exercise | M | — 32.8K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Senn AndrewSVP, Strategy and Business Dev | Option exercise | M | — 630 sh | Jan 21, 2026 traded Jan 17, 2026 |
| 19 | Heeson LeeEVP, Head of Incyte Intl | Grant or award | A | — 8,911 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Weitzel Gregory ThomasCFO | Disposition to issuer | D | $27K 2,159 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Hoyt CaseyDirector, Chief Executive Officer | Option exercise | M | — 40.1K sh | Jan 21, 2026 traded Jan 17, 2026 |
| 19 | Fitzgerald TraeChief Financial Officer | Option exercise | M | — 9,590 sh | Jan 21, 2026 traded Jan 17, 2026 |
| 19 | Deneke J HeathChairman, President and CEO | Option exercise | M | — 32.8K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Ways Douglas KirkDirector, Interim Chief Medical Officer | Disposition to issuer | D | — 400 sh | Jan 21, 2026 traded Dec 11, 2025 |
| 19 | Mills Desmond JSVP & Chief Accounting Officer | Option exercise | M | — 1,367 sh | Jan 21, 2026 traded Jan 18, 2026 |
| 19 | Patil Neena MEVP & Chief Legal Officer | Grant or award | A | — 8,852 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Morrissey Michael JamesEVP, Head of Tech. Operations | Grant or award | A | — 7,426 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Ways Douglas KirkDirector, Interim Chief Medical Officer | Grant or award | A | — 266 sh | Jan 21, 2026 traded Dec 11, 2025 |
| 19 | Mault William J.Executive VP and CFO | Option exercise | M | — 10.1K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Harris Kimberley D.Director | Grant or award | A | — 364 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Ways Douglas KirkDirector, Interim Chief Medical Officer | Grant or award | A | — 5,000 sh | Jan 21, 2026 traded Dec 11, 2025 |
| 19 | Macdonald AndrewSee Remarks | Option exercise | M | — 4,042 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Ways Douglas KirkDirector, Interim Chief Medical Officer | Option exercise | M | — 1,250 sh | Jan 21, 2026 traded Dec 11, 2025 |
| 19 | Weitzel Gregory ThomasCFO | Option exercise | M | — 6,149 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Carr PatriciaSVP, Chief Accounting Officer | Grant or award | A | — 2,370 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Freda FabrizioDirector | Grant or award | A | — 214 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Weitzel Gregory ThomasCFO | Disposition to issuer | D | $29K 2,351 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Pearce SamanthaEVP, Chief Commercial Officer | Grant or award | A | — 3,637 sh | Jan 21, 2026 traded Jan 16, 2026 |